Annals of Laboratory Medicine

Korean Society for Laboratory Medicine (대한진단검사의학회)
권호 표지
DOI QR코드

DOI QR Code

In-vitro Activity of Delpazolid and Comparator Agents Against Methicillin-resistant Staphylococcus aureus Involved in Bloodstream Infection

  • Jeong Su Park (Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Yun Jung Choi (Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Kyungmi Kwon (Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Seong Jin Choi (Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Song Mi Moon (Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Kyoung-Ho Song (Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Eu Suk Kim (Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Kyoung Un Park (Department of Laboratory Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine) ;
  • Hong Bin Kim (Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine)
  • Received : 2022.08.19
  • Accepted : 2022.11.29
  • Published : 2023.07.01
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

Acknowledgement

This work was supported by LegoChem Biosciences (grant No. 06-2022-0028).

References

  1. Nannini E, Murray BE, Arias CA. Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus. Curr Opin Pharmacol 2010;10:516-21. https://doi.org/10.1016/j.coph.2010.06.006
  2. Narita M, Tsuji BT, Yu VL. Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome. Pharmacotherapy 2007;27:1189-97. https://doi.org/10.1592/phco.27.8.1189
  3. Lewis PO, Heil EL, Covert KL, Cluck DB. Treatment strategies for persistent methicillin-resistant Staphylococcus aureus bacteraemia. J Clin Pharm Ther 2018;43:614-25. https://doi.org/10.1111/jcpt.12743
  4. Yu SH, Lee JH, Kim MC, Choi SH, Chung JW, Lee MK. Ten-year prevalence trends of phenotypically identified community-associated methicillin-resistant Staphylococcus aureus strains in clinical specimens. Ann Lab Med 2021;41:386-93. https://doi.org/10.3343/alm.2021.41.4.386
  5. Cho YS, Lim HS, Cho YL, Nam HS, Bae KS. Multiple-dose safety, tolerability, pharmacokinetics, and pharmacodynamics of oral LCB01-0371 in healthy male volunteers. Clin Ther 2018;40:2050-64. https://doi.org/10.1016/j.clinthera.2018.10.007
  6. Jeong JW, Jung SJ, Lee HH, Kim YZ, Park TK, Cho YL, et al. In vitro and in vivo activities of LCB01-0371, a new oxazolidinone. Antimicrob Agents Chemother 2010;54:5359-62. https://doi.org/10.1128/AAC.00723-10
  7. Zong Z, Jing W, Shi J, Wen S, Zhang T, Huo F, et al. Comparison of in vitro activity and MIC distributions between the novel oxazolidinone delpazolid and linezolid against multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in China. Antimicrob Agents Chemother 2018;62:e00165-18. https://doi.org/10.1128/AAC.00165-18
  8. CLSI. Performance standards for antimicrobial susceptibility testing, M100. 31th ed. Wayne, PA: Clinical and Laboratory Standards Institute, 2021.